Med Ed Report briefs

The Society for Academic CME is holding its first Summer Leadership Institute: Leadership Development for Leaders in CME, in July, at Johns Hopkins University School of Medicine. The Institute is aimed at helping assistant/associate deans and CME program directors to hone planning, media, interpersonal and other leadership skills.

The National Commission for Certification of CME Professionals has developed a practice test to help individuals prepare for its national certification exam. The test, available at www.NCCME.org/PracticeExam, consists of 45 questions and costs $45.

The ACCME released data on the number of accredited providers that restructured to comply with its redefinition of a commercial interest. In 2008 and 2009, ACCME said it reviewed 30 accredited providers and found that 17 would be considered commercial interests. Of those, 14 restructured and retained accreditation; three withdrew from accreditation.

Epocrates announced enhancements and functionality to its DocAlert messaging service: linking from alerts to features such as mobile detailing; follow-up emails now viewable on device with visuals like graphs and charts; and improved readability.
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.